English
-
-
The Shifting Epidemiology of Dengue: From Climate Change to Urbanization
Medscape5 minutes -
Dengue disease awareness
ISID39 minutes -
Controlling Dengue: Immunization Is a Pillar of Prevention
Medscape33 minutes -
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia
Takeda2 minutes -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
Dengue: Not Just 1 Virus, Not Just 1 Infection
Medscape15 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Antibody Levels over Time
Takeda2 minutes -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
Management of cases
Takeda1 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Dengue virus and pathobiology
Takeda1 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Clinical diagnosis and management of dengue
PAHO -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Dengue Clinical Case Management
CDC -
NS1 and its potential association with severe dengue
Takeda3 minutes -
Dengue - unanswered scientific questions
Takeda11 minutes -
Emerging Issues in Pediatric Dengue
WSPID50 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Resources for patient support
Takeda3 minutes -
Dengue fever and insecticide resistance in Aedes mosquitoes in Southeast Asia: a review
Takeda2 minutes -
Dengue virus infections among European travellers, 2015 to 2019
Takeda2 minutes -
Professor Adi Utarini – Eliminating Dengue
35 minutes -
Dengue serotypes
Takeda4 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Takeda2 minutes -
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis
Takeda2 minutes -
Dengue: a global threat
WSPID38 minutes -
Dengue vector control: what works best
WSPID20 minutes -
Mosquito Longevity
ADVA22 minutes -
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia
ADVA25 minutes -
Dengue Virus Life Cycle
HHMI BioInteractive4 minutes -
Dengue Prevention: Translating Knowledge into Action
Takeda
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2023 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021